← Companies|Charité Berlin
Ch

Charité Berlin

NPBerlin DEFounded 171018,000 employees
Private CapacadPrivateNeurologyOncologyCardiology
Platform: University Hosp
Market Cap
N/A
All Drugs
5
Clinical Trials
5
Failed / Terminated
2
FDA Approved
1
Drug Pipeline (5 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
CHA-IIT-658CHA-IIT-658Phase 1/21Gene EditingAPOC3CDK4/6iBladder Ca
CHA-IIT-211CHA-IIT-211Phase 11Cell TherapyGPRC5DTNFiBladder Ca
CHA-IIT-602CHA-IIT-602NDA/BLA1Gene EditingWEE1PLK4iRA
CHA-IIT-901CHA-IIT-901Approved1Gene EditingSMN2KRASG12DiPAH
CHA-IIT-311CHA-IIT-311Phase 21RadioligandWRNBETiCML
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)
2029-02-18
CHA-IIT-602 Ph3 Readout
RA
Ph3 Readout
2029-04-11
CHA-IIT-211 Interim
Bladder Ca
Interim
2029-10-16
CHA-IIT-901 Ph3 Readout
PAH
Ph3 Readout
2030-05-09
CHA-IIT-658 Ph2 Data
Bladder Ca
Ph2 Data
2031-06-23
CHA-IIT-311 Ph2 Data
CML
Ph2 Data